Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow CellsTransplantation, HomologousHematopoietic Stem Cell TransplantationBone and BonesGraft vs Host DiseaseTransplantation ConditioningLiver TransplantationWhole-Body IrradiationHematopoietic Stem CellsBone Marrow PurgingGraft SurvivalLeukemiaStem Cell TransplantationTransplantation ChimeraKidney TransplantationAnemia, AplasticBusulfanBone Marrow DiseasesTissue DonorsCyclophosphamideMultiple MyelomaCombined Modality TherapyTreatment OutcomeHematopoiesisRecurrenceBone Marrow ExaminationBone RemodelingHistocompatibility TestingLymphoma, Non-HodgkinTransplantation, IsogeneicRemission InductionTime FactorsMelphalanBone Marrow NeoplasmsPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell MobilizationAntigens, CD34HistocompatibilityMice, Inbred C57BLHematologic NeoplasmsHeart TransplantationImmunosuppressive AgentsGranulocyte Colony-Stimulating FactorLeukemia, Myeloid, AcuteGraft RejectionColony-Forming Units AssayLung TransplantationRadiation ChimeraAntineoplastic Combined Chemotherapy ProtocolsT-LymphocytesCells, CulturedCarmustineTransplantation ImmunologySurvival AnalysisCell TransplantationRetrospective StudiesBone DensityCell DifferentiationFlow CytometryLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic SyndromesImmunosuppressionPrecursor Cell Lymphoblastic Leukemia-LymphomaDisease-Free SurvivalOrgan TransplantationEtoposideLeukemia, MyeloidCytarabineSalvage TherapySurvival RateBone ResorptionFollow-Up StudiesAcute DiseaseCell SeparationHodgkin DiseaseLymphocyte DepletionGraft vs Tumor EffectHepatic Veno-Occlusive DiseaseGraft vs Host ReactionLeukocyte CountLymphomaHLA AntigensChimeraLeukocyte TransfusionLeukapheresisAntigens, CDSpleenPrognosisAntibodies, MonoclonalBlood Cell CountCyclosporineLeukocytes, MononuclearSevere Combined ImmunodeficiencyHematologic DiseasesBone NeoplasmsImmunophenotypingLymphocytes